DSpace at RU >

Browsing by Author Doorn, P.A. van

Full Text	Issue Date	Title	Author(s)
	2012	Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment	Eftimov, F.; Vermeulen, M; Doorn, P.A. van; Brusse, E.; Schaik, I.N. van, et al
	2011	Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy	Eijk, J.J.J. van; Alfen, N. van; Tio-Gillen, A.P.; Maas, Marijke; Herbrink, P., et al
	2011	Selective digestive tract decontamination decreases time on ventilator in Guillain-Barre syndrome	Eyssen, M.E.; Doorn, P.A. van; Jacobs, B.C.; Steyerberg, E.W.; Voort, P.H. van der, et al
	2010	Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial.	Schaik, I.N. van; Eftimov, F.; Doorn, P.A. van; Brusse, E.; Berg, L.H. van den, et al
	2010	Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy	Cats, E.A.; Pol, W.L. van der; Piepers, S.; Franssen, H.; Jacobs, B.C., et al
	2009	Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes.	Brugman, F.; Veldink, J.H.; Franssen, H.; Visser, M. de; Jong, J.M. de, et al
	2007	Contribution of central and peripheral factors to residual fatigue in Guillain-Barre syndrome.	Garssen, M.P.; Schillings, M.L.; Doorn, P.A. van; Engelen, B.G.M. van; Zwarts, M.J.
	2007	Ptosis as a feature of late-onset glycogenosis type II. Response to: Ravaglia S, Repetto A, De Filippi P, Danesino C.	Leen, W.; Groen, W.B.; Vos, A.M.C.; Cruysberg, J.R.M.; Doorn, P.A. van, et al
	2007	Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome.	Geleijns, K.; Emonts, M.; Laman, J.D.; Rijs, W. van; Doorn, P.A. van, et al
	2007	The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data.	Engelen, B.G.M. van; Veenendaal, H. van; Doorn, P.A. van; Faber, C.G.; Hoeven, J.H. van, et al
	2007	TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations.	Seelaar, H.; Schelhaas, H.J.; Azmani, A.; Kusters, B.; Rosso, S., et al
	2006	Ptosis as a feature of late-onset glycogenosis type II.	Groen, W.B.; Leen, W.G.; Vos, A.M.C.; Cruysberg, J.R.M.; Doorn, P.A. van, et al
	2005	Inclusion body myositis Clinical features and clinical course of the disease in 64 patients.	Badrising, U.A.; Maat-Schieman, M.L.; Houwelingen, J.C. van; Doorn, P.A. van; Duinen, S.G. van, et al
	2004	The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands.	Wirtz, P.W.; Dijk, J.G. van; Doorn, P.A. van; Engelen, B.G.M. van; Kooi, A.J. van der, et al
	2004	Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.	Hout, J.M. van den; Kamphoven, J.H.; Winkel, L.P.; Arts, W.F.M.; Klerk, J.B.C. de, et al